Skip to main content
Clinical Trials/CTRI/2022/10/046844
CTRI/2022/10/046844Not yet recruiting未知

A Clinical Study to asses the Ruchya and Agnisandipan effect of Lavana-ardraka on Aruchi and Agnimandya in Post Covid-19 Cases.

Dr Kajal Shah0 sites0 target enrollmentStarted: TBDLast updated:

Trial Snapshot

Phase
未知
Status
Not yet recruiting
Sponsor

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Inclusion Criteria

  • Individuals of either sex,above 18 years and below 60 years of age
  • 1.RTPCR based diagnosed post covid-19 cases
  • 2.People who have loss of taste and anorexia as symptoms post illness(covid-19)
  • 3.People who are ready to participate in the research and take lavana ardraka yog for
  • the duration of 28 days in the prescribed quantity.

Exclusion Criteria

  • Individuals with uncontrolled,unstable co-morbidities.
  • 1.Individuals with pre existing respiratory conditions.
  • 2.Immunocompromised individuals or those on immunosuppressants.
  • 3.Pregnant and lactating females.
  • 4.Patients on or requiring parenteral nutrition.
  • 5.Before or during the course of study, if any subject is found to have vishamagni, he
  • will be excluded from the study for accuracy in results.
  • 6.Contraindications mentioned in ayurveda for lavana and ardraka.

Investigators

Sponsor
Dr Kajal Shah

Similar Trials